MARSHALL WACE, LLP

Position in LUNG — Pulmonx Corp

CIK 1318757 LONDON, X0

Position in LUNG

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$299,959

-$191,441 QoQ

Shares Held

230,738

+21.6% QoQ

Ownership

0.537%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 108 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. LUNG ranks #56 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$299,959	230,738	+21.6%	Shares	Other	2026-08-13
2025-06-30	$491,400	189,730	-58.7%	Shares	Other	2025-08-13
2025-03-31	$3,095,408	459,942	+705.4%	Shares	Other	2025-05-15
2024-09-30	$473,433	57,109	-53.7%	Shares	Other	2024-11-14
2024-03-31	$1,143,111	123,313	+45.4%	Shares	Other	2024-05-15
2023-12-31	$1,081,034	84,787	-45.6%	Shares	Other	2024-02-14
2023-09-30	$1,610,302	155,886	+32.9%	Shares	Other	2023-11-14
2023-03-31	$1,311,056	117,268	+261.0%	Shares	Other	2023-05-15
2022-12-31	$273,814	32,481	+111.7%	Shares	Other	2023-02-14
2022-06-30	$225,819	15,341	-33.2%	Shares	Other	2022-08-15
2021-06-30	$1,013,348	22,968	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.